Quarterly results round-up: Dentsply and Thoratec see double-digit sales growth, while Fresenius doubles income
This article was originally published in Clinica
Dental implant firm Dentsply International reported impressive 26% revenue growth during its first fiscal quarter of 2012 at $716.4m. However, the firm saw its Q1 net income slip to $53.3m or $0.37 per diluted share, compared with $69.1m or $0.48 per diluted share during the same period last year, as it was hit by increased expenses and restructuring costs. On an adjusted basis, earnings increased to $0.52 per share from $0.50 per diluted share in last year's Q1.